Current Vaccine News and Events

Current Vaccine News and Events, Vaccine News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
SARS-CoV-2 reacts to antibodies of virus from 2003 SARS outbreak, new study reveals
A new study demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa, according to research published today by scientists from Oregon Health & Science University. (2021-01-25)

Governments need to set clear rules for vaccinating health care workers against COVID-19
An analysis undertaken by Faculty of Law professors and a physician-researcher from the Faculty of Medicine at the University of Ottawa feels provincial and territorial governments should set clear rules for vaccinating health care workers against SARS-CoV-2, the virus that causes COVID-19, in public and private settings. (2021-01-25)

Continued strict control measures needed to reduce new COVID-19 strains
A group of scientists is calling on governments to consider the continued use of strict control measures as the only way to reduce the evolution and spread of new COVID-19 variants. The experts in evolution, virology, infectious disease and genomics warn that while governments are negotiating a 'precarious balance' between saving the economy and preventing COVID-19 fatalities, stronger action now is the best way to mitigate against more serious outcomes from such virulent strains later. (2021-01-24)

Rhesus macaques develop promising immune response to SARS-CoV-2
In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine. (2021-01-22)

Massey researchers review geographic factors that affect HPV vaccination rates
A team of researchers from VCU Massey Cancer Center conducted the first-ever systematic review of area-level data reported in the United States between 2006 and 2020 to determine how geography, neighborhoods and sociodemographic factors impact HPV vaccination rates among adolescents and young adults. The study was published in Cancer Epidemiology, Biomarkers and Prevention. (2021-01-22)

Vaccine produces long-lasting anti-tumor response in patients with melanoma
Patients treated with a vaccine tailored to mutated proteins on patients' own tumor cells, continue to have a strong immune response to the cancer four years after being vaccinated. Results demonstrate the ability of personalized cancer vaccines to provide long-term immunity against some cancers. (2021-01-21)

Age-based COVID-19 vaccine strategy that saves most lives prioritizes elderly, modeling shows
Vaccinating people over 60 is the most effective way to mitigate mortality from COVID-19, a new age-based modeling study suggests. (2021-01-21)

Why older adults must go to the front of the vaccine line
A new global, mathematical modeling study pubilshed in the journal Science shows that in most cases prioritizing older adults for COVID-19 vaccines saves the most lives. It also found that, in some cases, more lives could be saved and infections prevented if those who've already tested positive step to the back of the line. (2021-01-21)

Hope for a vaccination against Staphylococcus areus infections?
Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunisation against multi-resistant strains is seen as a potentially valuable alternative to antibiotic therapy. However, all vaccine candidates so far have been clinically unsuccessful. With an epitope-based immunisation, scientists at Cologne University Hospital and the German Center for Infection Research (DZIF) have now described a new vaccination strategy against S. aureus in the Nature Partner Journal NPJ VACCINES. (2021-01-20)

Incentivizing vaccine adherence: could it be the key to achieving herd immunity?
To achieve success, experts estimate that at least 70 to 90 percent of the population must be inoculated with a COVID-19 vaccine to achieve herd immunity, but how can we ensure folks will voluntarily receive a vaccine? An examination of scientific evidence on incentivizing vaccine adherence found that modest financial incentives resulted in as much as a 7-fold increase in adherence compared to no incentives. (2021-01-20)

Set clear rules for vaccinating health care workers against SARS-CoV-2
Provincial and territorial governments should set clear rules for vaccinating health care workers against SARS-CoV-2, the virus that causes COVID-19, in public and private settings, and should not leave this task to employers, according to an analysis in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/content/cmaj/early/2021/01/19/cmaj.202755.full.pdf. (2021-01-19)

Rush researchers demonstrate success with new therapy for COVID-19
A new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice. (2021-01-19)

New method to assist fast-tracking of vaccines for pre-clinical tests
A new method to synthesize vaccines safely and quickly should see much faster pre-clinical testing to pursue strategies to combat novel pathogens, something the COVID pandemic has shown is necessary. (2021-01-18)

UW researchers develop tool to equitably distribute limited vaccines
Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person's age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs. (2021-01-15)

T cells linked to myelin implicated in MS-like disease in monkeys
Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disease in monkeys that's similar to multiple sclerosis in people. By linking two specific T cells to the loss of myelin, scientists say the new study opens the possibility of developing an antiviral therapy that could be especially useful for newly diagnosed cases of multiple sclerosis. (2021-01-15)

Algorithms designed to study language predict virus 'escape' mutations for SARS-CoV-2 and others
By bridging the conceptual divide between human language and viral evolution, researchers have developed a powerful new tool for predicting the mutations that allow viruses to 'escape' human immunity or vaccines. (2021-01-14)

COVID-19: Science scepticism may be reinforced by UK rush to approve vaccines
Former director of public health Professor John Ashton has said that scientific scepticism may be reinforced by the UK's rush to approve COVID vaccines for public use and the apparent political desire to be the first out of the blocks in contrast to our European neighbours. (2021-01-14)

Study: Many summer camps don't require childhood immunizations
Nearly half of summer camps surveyed by researchers didn't have official policies requiring campers be vaccinated, and just 39% mandated staffers be vaccinated. (2021-01-13)

COVID-19 vaccine creates incentive to improve our health
While we wait for our turn to get vaccinated against SARS-CoV-2, we could - and probably should - use the time to make sure we bring our healthiest emotional and physical selves to the treatment, a new review of previous research suggests. (2021-01-13)

Depression and stress could dampen efficacy of COVID-19 vaccines
Health behaviors and emotional stressors can alter the body's ability to develop an immune response to vaccines, including--potentially--the new COVID-19 vaccines. Simple interventions, including exercising and getting a good night's sleep in the 24 hours before vaccination, may maximize the vaccine's initial effectiveness. (2021-01-13)

Another common cold virus? Modeling SARS-CoV-2's progress through the ages
What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic -- circulating in the general population -- and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a model developed by Emory and Penn State scientists. (2021-01-12)

Strategy tested in mice protects against SARS-CoV-2 & coronaviruses that represent human threats
An immunization strategy tested in mice protects against infection from SARS-CoV-2, as well as from potentially emerging animal coronaviruses, researchers say. (2021-01-12)

Is the COVID-19 vaccine safe for nursing mothers?
The Academy of Breastfeeding Medicine (ABM) does not recommend cessation of breastfeeding for individuals who are vaccinated against COVID-19. (2021-01-12)

Nanoparticle immunization technology could protect against many strains of coronaviruses
Caltech researchers are studying a new type of immunization that may be able to protect against many variants of viruses. (2021-01-12)

Higher vaccine rates associated with indicative language by provider, more efficient
New research from Boston Medical Center finds that using clear, unambiguous language when recommending HPV vaccination both increases vaccine acceptance and increases conversation efficiency while preserving patient satisfaction. (2021-01-12)

Scientists reach new milestone in vaccine development for leishmaniasis
Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines. (2021-01-11)

Breakthrough on diarrhea virus opens up for new vaccines
Researchers at UmeƄ University in Sweden have for the first time at the atomic level succeeded in mapping what a virus looks like that causes diarrhea and annually kills about 50,000 children in the world. The discovery may in the long run provide the opportunity for completely new types of treatments for other viral diseases such as COVID-19. (2021-01-11)

Nanoparticle vaccine for COVID-19
Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature. (2021-01-08)

Experts tap into behavioral research to promote COVID-19 vaccination in the US
Behavioral science and marketing researchers are laying out a range of strategies to help convince people to get vaccinated. (2021-01-07)

Treating an autoimmune disease in mice with an mRNA vaccine
Christina Krienke and colleagues have designed an mRNA vaccine that delayed the onset of and reduced the severity of multiple sclerosis-like disease in mice. (2021-01-07)

New defense against dengue and emerging mosquito-borne viruses
New treatments to cut the global death rate from dengue, Zika and West Nile viruses could result from research led by The University of Queensland. Associate Professor Daniel Watterson from UQ's School of Chemistry and Molecular Biosciences said the team identified an antibody that improved survival rates in laboratory trials and reduced the presence of virus in the blood. (2021-01-07)

Study: Black Americans, women, conservatives more hesitant to trust COVID-19 vaccine
A survey of approximately 5,000 Americans suggests that 31.1 percent of the US public does not intend to get the COVID-19 vaccine once it becomes available to them - and the likelihood of vaccine refusal is highest among Black Americans, women and conservatives. (2021-01-06)

Vaccine myths on social media can be effectively reduced with credible fact checking
Researchers found that fact-check tags located immediately below or near a social media post can generate more positive attitudes toward vaccines than misinformation alone, and perceived source expertise makes a difference. (2021-01-06)

Facebook posts help facilitate belief that HPV vaccine is dangerous to health
Social media has a history of being a popular place for sexual health discussions, and the HPV vaccine is one of the most discussed vaccines on the internet. Monique Luisi, an assistant professor in the University of Missouri School of Journalism, suggests some HPV vaccine-related Facebook posts can help facilitate beliefs that the HPV vaccine is dangerous to one's health. She believes it could inform officials for the ongoing COVID-19 vaccine roll out and distribution. (2021-01-05)

COVID-19 generally 'mild' in young children: Evidence review
Babies and asymptomatic cases account for up to half of COVID-19 infections in the under-five age group, which has implications for vaccination programs, a new UNSW study has found. (2021-01-05)

Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines
Reports of possible allergic reactions to COVID-19 vaccines have raised public concern; however, allergists note that allergic reactions to vaccines are rare, and COVID-19 vaccine allergic reactions will have a similarly low rate of occurrence. Individuals with a history of anaphylaxis to an injectable drug or vaccine containing polyethylene glycol or polysorbate should speak with an allergist before getting vaccinated, but patients with severe allergies to foods, oral drugs, latex or venom can safely receive the COVID-19 vaccines. (2020-12-31)

Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy
Data from the COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc., demonstrated 94.1 percent efficacy in preventing symptomatic COVID-19. (2020-12-30)

Peer-reviewed report on Moderna COVID-19 vaccine publishes
The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19. Investigators identified no safety concerns and no evidence of vaccine-associated enhanced respiratory disease (VAERD). (2020-12-30)

Pregnant women with COVID-19 pass no virus but fewer-than-expected antibodies to newborns
Pregnant women may be especially vulnerable to developing more severe cases of COVID-19, but little is known about their anti-SARS-CoV-2 immune response or how it may affect their offspring. A new study provides new insights that could help improve care for these women and their newborns and emphasizes the need for pregnant women to be considered in vaccine rollout plans. (2020-12-22)

Global disparities in vaccination persist and leave many children at risk
Even before the COVID-19 pandemic, tens of millions of children worldwide were not receiving basic doses of vaccines. New research finds there continue to be significant disparities in childhood vaccination, and poorer children from under-represented and minority groups in most countries are more likely to be less fully vaccinated with all the recommended immunizations. A special supplement to the American Journal of Preventive Medicine looks at the barriers and challenges that limit or prevent access to vaccines in vulnerable children. (2020-12-22)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.